27 November
The HMDS Annual Haematopathology Update: Incorporating novel diagnostics into patient management

Royal Armouries, Leeds, LS10 1LT

The field of myeloma and chronic lymphocytic leukemia  is changing at pace. Due to significant advances in technology, particularly in genomics, our understanding of normal and neoplastic haemopoiesis is constantly improving. However the real challenge is how these technological advances and genomic information can be transferred from the laboratory to the clinical management of the individual patient. The study day will focus on the recent advances seen within myeloma, chronic lymphocytic leukemia and myeloproliferations and how diagnostic advances guide the individual patient pathway.

Dr Charlotte Pawlyn (Royal Marsden)
Prof Nick Cross (Salisbury)

….. along with Leeds University and HMDS staff
Prof Peter Hillmen, Dr Andy Rawstron, Dr Tal Munir

CLL session:
Diagnosis, clinical management of CLL and disease monitoring in the era of novel therapies

Myeloma session:
Clinical and laboratory updates from recent UK myeloma trials

Dickinson Memorial Lecture:
Plasma cell myeloma (USA speaker)

Myeloproliferative Neoplasms session:
Rare and atypical myeloproliferations – mastocytosis, eosinophilia and monocytosis

Case studies: various disease areas to be covered

Interactive case study session with integrated diagnostics in challenging and unusual cases

REGISTRATION FEE: £50 (inclusive of VAT)


Hartley Taylor Medical Communications Ltd
2, St George’s Court | St George’s Park
Kirkham | PR4 2EF